Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 3, 2007, Pages 245.e1-245.e11

  Bignotti, Eliana ^a   Tassi, Renata A ^a   Calza, Stefano ^a   Ravaggi, Antonella ^a   Bandiera, Elisabetta ^a   Rossi, Elisa ^a   Donzelli, Carla ^a   Pasinetti, Brunella ^a   Pecorelli, Sergio ^a   Santin, Alessandro D ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

complementary DNA; gene expression profiling; metastasis associated gene; microarray; ovarian cancer; ovarian serous papillary carcinoma

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; CHEMOKINE; COLLAGEN; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR; HEPARIN; HEPSIN; HYALURONIC ACID BINDING PROTEIN; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; SOMATOMEDIN; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; CXCL12 GENE; DNA MICROARRAY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; OVARY METASTASIS; OVARY TUMOR; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33847397773     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.10.874     Document Type: Article

References (25)

1. Jemal A. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. In: DiSaia P.J., and Creasman W.T. (Eds). Epithelial ovarian cancer: clinical gynecologic oncology (2002), Mosby-Year Book, Inc, St Louis 185-206
3. Wang N. Cytogenetics and molecular genetics of ovarian cancer. Am J Med Genet 115 (2002) 157-163
4. Le Page C., Provencher D., Maugard C.M., Ouellet V., and Mes-Masson A.M. Signature of a silent killer: expression profiling in epithelial ovarian cancer. Exp Rev Mol Diagn 4 (2004) 157-167
5. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
6. Weigelt B., Glas A.M., Wessels L.F., Witteveen A.T., Peterse J.L., and van't Veer L.J. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 100 (2003) 15901-15905
7. D'Arrigo A., Belluco C., Ambrosi A., et al. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115 (2005) 256-262
8. Bignotti E., Tassi R.A., Calza S., et al. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103 (2006) 405-416
9. Konecny G., Untch M., Pihan A., et al. Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res 7 (2001) 1743-1749
10. Fishman D.A., Kearns A., Larsh S., Enghild J.J., and Stack M.S. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalyzed release of the urinary-type-plasminogen-activator N-terminal fragment. Biochem J 341 (1999) 765-769
11. Fischer K., Lutz V., Wilhelm O., et al. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. FEBS Lett 438 (1998) 101-105
12. Rabbani S.A., and Xing R.H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int J Oncol 12 (1998) 911-920
13. Kobayashi H., Suzuki M., Tanaka Y., Hirashima Y., and Terao T. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem 276 (2001) 2015-2022
14. Sato S., Kopitz C., Schmalix W.A., et al. High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread. FEBS Lett 528 (2002) 212-216
15. Volpert O.V., Lawler J., and Bouck N.P. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci U S A 26 (1998) 6343-6348 95
16. Bertin N., Clezardin P., Kubiak R., and Frappart L. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res 57 (1997) 396-399
17. Trojan L., Schaaf A., Steidler A., et al. Identification of metastasis associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 25 (2005) 183-191
18. Kodama J., Hashimoto I., Seki N., et al. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Anticancer Res 21 (2001) 2983-2987
19. Basset P., Bellocq J.P., Wolf C., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 (1990) 699-704
20. Rouyer N., Wolf C., Chenard M.P., et al. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 14 (1994) 269-275
21. Mueller J., Brebeck B., Schmalfeldt B., Kuhn W., Graeff H., and Hofler H. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch 437 (2000) 618-624
22. Scotton C.J., Wilson J.L., Milliken D., Stamp G., and Balkwill F.R. Epithelial cancer cell migration: A role for chemokine receptors?. Cancer Res 61 (2001) 4961-4965
23. Kryczek I., Lange A., Mottram P., et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65 (2005) 465-472
24. Zou W., Machelon V., Coulomb-L'Hermin A., et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7 (2001) 1339-1346
25. Hendrix C.W., Flexner C., MacFarland R.T., et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44 (2000) 1667-1673